⚡ Interrogation des APIs scientifiques en cours…
⚡ Interrogation des APIs scientifiques en cours…
Authors' conclusion
Does not affect the score
Publi-Score
Fidelity
Abstract (PubMed)
Ultraprocessed food (UPF) consumption is associated with noncommunicable disease risk, yet no trial has assessed its health impact within the context of national dietary guidelines. In a 2 × 2 crossover randomized controlled feeding trial, 55 adults in England (body mass index ≥25 to <40 kg m, habitual UPF intake ≥50% kcal day) were provided with two 8-week ad libitum diets following the UK Eatwell Guide: (1) minimally processed food (MPF) and (2) UPF, in a random order. Twenty-eight people were randomized to MPF then UPF, and 27 to UPF then MPF; 50 participants comprised the intention-to-treat sample. The primary outcome was the within-participant difference in percent weight change (%WC) between diets, from baseline to week 8. Participants were blinded to the primary outcome. MPF (%WC, -2.06 (95% confidence interval (CI), -2.99, -1.13) and UPF (%WC, -1.05 (95% CI, -1.98, -0.13)) resulted in weight loss, with significantly greater %WC on MPF (Δ%WC, -1.01 (95% CI, -1.87, -0.14), P = 0.024; Cohen's d, -0.48 (95% CI, -0.91, -0.06)). Mild gastrointestinal adverse events were common on both diets. Findings indicate greater weight loss on MPF than UPF diets and needing dietary guidance on food processing in addition to existing recommendations. Clinicaltrials.gov registration: NCT05627570 .
Coeff. authors = avg(0.40, 0.85) = 0.63
Coeff. editorial = avg(1.00, 0.70) = 1.00
min(0.63, 1.00) ← lowest dominates
80.3/100 × 0.63 × 100
Calorie Restriction with or without Time-Restricted Eating in Weight Loss.
Liu D — 2022 · New England Journal of Medicine
Sugar-sweetened beverages and genetic risk of obesity.
Qi Q. — 2012 · The New England journal of medicine
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
Levin EG — 2021 · The New England Journal of Medicine
A randomized trial of sugar-sweetened beverages and adolescent body weight.
Ebbeling CB — 2012 · New England Journal of Medicine
Once-Weekly Semaglutide in Adults with Overweight or Obesity.
Wilding JPH — 2021 · The New England Journal of Medicine
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.
Shai I — 2008 · New England Journal of Medicine